This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Diabetes
  • /
  • Efficacy and Safety of LixiLan, a Titratable Fixed...
Journal

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.

Read time: 1 mins
Published:1st Nov 2016
Author: Aroda VR, Rosenstock J, Wysham C, Unger J, Bellido D, González-Gálvez G et al.
Source: Diabetes Care
Availability: Pay for access, or by subscription
Ref.:Diabetes Care. 2016;39(11):1972-1980.
DOI:10.2337/dc16-1495
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest